Open AccessChanges in Body Mass Index Among Antiretroviral Therapy Naïve People Living with HIV in Southeastern Nigeria
Author(s) -
John Olajide Olawepo,
Jennifer R. Pharr,
Chad L. Cross,
Babayemi O Olakunde,
Chinedu Aniekwe,
Mercy Niyang,
Raisa Kabir,
Ayodotun Olutola
Publication year - 2021
Publication title -
global journal of health science
Language(s) - English
Resource type - Journals
eISSN - 1916-9744
pISSN - 1916-9736
DOI - 10.5539/gjhs.v13n6p14
Subject(s) - underweight , body mass index , medicine , overweight , obesity , regimen , antiretroviral therapy , demography , human immunodeficiency virus (hiv) , gerontology , antiretroviral treatment , viral load , immunology , sociology
The proportion of people living with HIV (PLHIV) who are overweight or obese is rising, leading to a double epidemic of HIV and obesity. The purpose of this retrospective longitudinal study was to examine changes in body mass index (BMI) among PLHIV who were new to antiretroviral therapy (ART) in two states in Southeastern Nigeria. The BMI at baseline and 12 months were compared and the difference in proportions in each BMI category was tested. The association between the BMI at 12 months and the demographic and/or clinical variables was examined using multiway analysis of covariance. The study included 2,146 participants. After 12 months on ART, the number of participants who were obese increased by 135% (81 to 190), while those who were underweight decreased by 130% (306 to 133). Overall, the BMI increased in 30.2% of the participants. Further analysis showed that age (p=.009; η2=.005), baseline BMI (p<.001; η2=.435), baseline regimen (p<.001; η2=.031), HIV stage (p=.039; η2=.007) and CD4 category (p<.001; η2=.012) were all associated with increased BMI after 12 months of ART. Healthcare providers should be mindful of the likelihood of excess weight gain among PLHIV who are on ART and develop a plan to proactively address it.